Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
gene therapy
Biotech
Novartis ignites new stage of Voyager pact with $15M capsid deal
Novartis is paying Voyager $15 million to take up its option on a novel capsid for use in a rare neurological disease gene therapy program.
Nick Paul Taylor
Sep 5, 2024 9:45am
Precigen laying off staff to eke out cash for approval filing
Aug 7, 2024 5:46am
James Wilson leaving Penn to launch two new biotechs
Aug 1, 2024 10:58am
Pfizer takes $230M hit after axing failed DMD gene therapy
Jul 30, 2024 8:15am
Lexeo links gene therapy to improvements in rare heart disease
Jul 15, 2024 9:46am
Taysha links gene therapy to motor gains in small Rett study
Jun 18, 2024 11:44am
